THE 1998 JAMES RANKIN ORATION: Reducing the toll of opioid overdose deaths in Australia
WAYNE HALL
National Drug and Alcohol Research Centre University of New South Wales, Australia
Wayne Hall PhD, Executive Director, National Drug and Alcohol Research Centre, University of New South Wales, Sydney NSW 2052, Australia.
Search for more papers by this authorWAYNE HALL
National Drug and Alcohol Research Centre University of New South Wales, Australia
Wayne Hall PhD, Executive Director, National Drug and Alcohol Research Centre, University of New South Wales, Sydney NSW 2052, Australia.
Search for more papers by this authorAbstract
Opioid overdose mortality among young adults in Australia has increased consistently over the past several decades. Among Australian adults aged 15–44 years, the number of these deaths has increased from six in 1964 to 600 in 1997. The rate (per million adults in this age group) increased 55-fold, from 1.3 in 1964 to 71.5 in 1997. The proportion of all deaths in adults in this age group caused by opioid overdose increased from 0.1% in 1964 to 7.3% in 1997. The magnitude of the increase makes it unlikely to be an artefact of changes in diagnosis, especially as similar increases have also been observed in other countries. These trends are also consistent with historical information which indicates that illicit heroin use first came to police attention in Sydney and Melbourne in the late 1960s. There is an urgent need to implement and evaluate a variety of measures to reduce the unacceptable toll of opioid overdose deaths among young Australians. These include: peer education about the risks of polydrug use and overdose after resuming opioid use after periods of abstinence, and attracting more dependent users into opioid maintenance treatment. Measures are also needed to improve responses to overdose by encouraging witnesses to call ambulances, training drug users in CPR, and trialling distribution of the opiate antagonist naloxone to users at high risk of overdose.
References
- 1 Hall W., Darke S.. Trends in opiate overdose deaths in Australia 1979–1995. Drug Alcohol Depend 1998; 52: 71–7.
- 2 Lynskey MT, Hall W.. Cohort trends in age of initiation to heroin use. Drug Alcohol Rev 1998; 17: 289–97.
- 3 Frischer M., Goldberg D., Rahman M., Berney L.. Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994, Addiction 1997; 92: 419–27.
- 4 O'Doherty M., Farrington A.. Estimating local opioid addict mortality. Addict Res 1997; 4: 321–7.
- 5 Oppenheimer E., Tobbutt C., Taylor C., Andrew T.. Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction 1994; 89: 1299–308.
- 6 Perucci CA, Davoli M., Rapiti E., Abeni DD, Forastieri F.. Mortality of intravenous drug users in Rome: a cohort study. Am J Pub Health 1991; 81: 1307–10.
- 7 Hall W., Darke S.. Trends in opiate overdose in Australia 1979–1995. NDARC technical report no. 49, Sydney, 1997.
- 8 Chen K., Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health 1995; 85: 41–7.
- 9 Lynskey M., Hall W.. Jurisdictional trends in opioid overdose deaths 1988–1996. Aust NZ J Public Health 1998; 22: 802–7.
- 10 Hall W., Degenhardt L., Lynskey M.. Trends in opioid overdose and suicide mortality in young adults in Australia 1964–1997. NDARC technical report no. 67. Sydney: National Drug and Alcohol Research Centre, 1999.
- 11 Darke S., Zador D., Sunjic S.. Toxicological findings and circumstances of heroin-related deaths in South Western Sydney, 1995. NDARC technical report no. 40, Sydney: National Drug and Alcohol Research Centre, 1997.
- 12 Sanchez J., Rodriguez B., De La Fuente L., et al. The state information system in drug abuse (SEIT) working group. Opiates or cocaine: mortality from acute reactions in six major Spanish cities. J Epidem Comm Health 1995; 49: 54–60.
- 13 Manderson D.. From Mr Sin to Mr Big: a history of Australian drug laws. Melbourne: Oxford University Press, 1993.
- 14 McCoy A.. Drug Traffic: narcotics and organized crime in Australia. Sydney: Harper and Row, 1980.
- 15 Robins LN. Vietnam veterans' rapid recovery from heroin addiction: a fluke or normal expectation. Addiction 1993; 88: 1041–54.
- 16 Robins LN, Helzer JE, Davis DH. Narcotic use in Southeast Asia and afterward: an interview study of 898 Vietnam returnees. Arch Gen Psychiatr 1975; 32: 955–61.
- 17 Ward J., Mattick R., Hall W.. Key issues in methadone maintenance treatment. Sydney: University of New South Wales Press, 1992.
- 18 Mattick RPM, Hall W.. A treatment outline for approaches to opioid dependence. National Drug Strategy monograph no. 21. Canberra: Australian Government Publishing Service, 1993.
- 19 Ward J., Mattick R., Hall W.. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic Press, 1998.
- 20 Robins LN, Przybeck TR. Age of onset of drug use as a predictor in drug and other disorders. In: CL Jones, RJ Battjes, eds. Etiology of drug abuse: implications for prevention. Washington, DC: US Government Printing Office, 1985.
- 21 Darke S., Zador D.. Fatal heroin overdose: a review. Addiction 1996; 91: 1757–64.
- 22 Australian Bureau of Criminal Intelligence. Australian illicit drug report 1996–97. Canberra: Australian Bureau of Criminal Intelligence, 1997.
- 23 Hando J., Darke S.. NSW drug trends, 1997: findings from the illicit drug reporting system (IDRS). NDARC technical report no. 56. Sydney: National Drug and Alcohol Research Centre, 1998.
- 24 Maher L.. Illicit drug reporting system (IDRS): ethnographic component. NDARC Technical Report No. 36. Sydney: National Drug and Alcohol Research Centre, 1996.
- 25 Maher L., Dixon D., Lynskey M., Hall W.. Running the risks: heroin, health and harm in South West Sydney. NDARC monograph no. 38. Sydney: National Drug and Alcohol Research Centre, 1998.
- 26 Darke S., Hall W., Weatherburn D., Lind B.. Fluctuations in heroin purity and the incidence of fatal heroin overdose in South Western Sydney, 1993–1995. NDARC technical report number 58. Sydney: National Drug and Alcohol Research Centre, 1998.
- 27 Australian Bureau of Criminal Intelligence. Australian illicit drug report 1996–97. Canberra: Australian Bureau of Criminal Intelligence, 1997.
- 28 Weatherburn D., Lind B.. Drug law enforcement and its impact on the heroin market. Sydney: NSW Bureau of Crime Statistics and Research, 1995.
- 29 Darke S., Hall W.. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995; 39: 231–5.
- 30 Darke S., Ross J., Hall W.. Benzodiazepine use among injecting heroin users. Med J Aust 1995; 162: 645–7.
- 31 Darke S., Ross J., Hall W.. The injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend 1996; 43: 191–8.
- 32 Darke S., Ross J., Hall W.. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 1996; 91: 405–11.
- 33 Tagliaro F., Battisti ZD, Smith FP, Marigo M.. Death from heroin overdose: findings from hair analysis. Lancet 1998; 351: 1923–5.
- 34 Zador D., Sunjic S., Basili H.. Deaths in methadone maintenance treatment in New South Wales, 1990–1995. In: W. Hall, ed. Proceedings of An International Opioid Overdose Symposium, NDARC monograph no. 35. Sydney: National Drug and Alcohol Research Centre, 1998.
- 35 Sunjic S., Zador D., Basili H.. Methadone-related deaths in New South Wales, July 1990-December 1995. In: W. Hall, ed. Proceedings of An International Opioid Overdose Symposium. NDARC monograph no. 35. Sydney: National Drug and Alcohol Research Centre, 1998.
- 36 Caplehorn JRM, Dalton SYN, Cluff MC, Pertness AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89: 203–7.
- 37 Farrell M., Strang J.. The lure of masterstrokes: drug legalization. Br J Addict 1990; 85: 5–7.
- 38 Uchtenhagen A., Dobler-Miklos A., Gutzwiller F.. Medically controlled prescription of narcotics: fundamentals, research plan, first experiences. Berne: Swiss Federal Office of Public Health, 1994.
- 39 A. Uchtenhagen, F. Gutzwiller, A. Dobler-Mikola. (eds) Programme for a medical prescription of narcotics: final report of the research representatives. Summary of the synthesis report. University of Zurich, July 1997.
- 40 Hall W., Mattick RP, Saunders J., Wodak A.. 1997. Rapid opiate detoxification treatment. Drug Alcohol Rev 1997; 325–7.
- 41 Mattick RP, Bell J., Daws L., White JM, O'Brien S., Harris S.. Review of the evidence on the effectiveness of antagonists in managing opioid dependence. NDARC monograph no. 34. Sydney: National Drug and Alcohol Research Centre, 1998.
- 42 Hall W.. The Australian debate about the legalisation of heroin and other illicit drugs, 1988–1991. J Drug Issues 1992; 22: 563–77.
- 43
Makkai T.,
McAllister I..
Patterns of drug use in Australia, 1985–95. Canberra: Australian Government Publishing Service, 1998.
10.1037/e677672010-001 Google Scholar
- 44 Bammer G.. Report and recommendations of stage 2 feasibility research into the controlled availability of opioids. Canbera: National Centre for Epidemiology and Population Health and Australian Institute of Criminology, 1995.
- 45 Hall W.. The Swiss scientific studies of medically prescribed narcotics. NDARC technical report no. 43. Sydney: National Drug and Alcohol Research Centre, 1997.
- 46 Parliament of New South Wales. Joint Select Committee Into Safe Injecting Rooms. Report on the establishment of safe injecting rooms. Sydney: Parliament of New South Wales, 1998.
- 47 Ritter A., Kutin J., Lintzeris N., Bammer G.. Expanding treatment options for heroin dependence in Victoria: buprenorphine, LAAM, naltrexone and slow-release oral methadone. New pharmacotherapies project-feasibility phase. Melbourne: Turning Point Alcohol and Drug Centre, 1997.
- 48 Lenton S., Ali R., Stockwell T.. Workshop on preventing opioid overdose deaths. In W. Hall. (ed) Proceedings of An International Opioid Overdose Symposium. NDARC Monograph No. 35. Sydney: National Drug and Alcohol Research Centre, 1998.
- 49 Darke S., Hall W.. The distribution of naloxone to heroin users. Addiction 1997; 92: 1195–9.